Robert W Holloway MD FACOG, FACS

PubMed

• Corrigendum to 'OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients...
  Premal H Thaker, Debra L Richardson, Andrea R Hagemann, Robert W Holloway, Mark Reed
  Gynecologic Oncology. 2025-11-06
• A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonolin Patients with Recurrent Platinum-Resistant Ovarian Cancer.
  Robert W Holloway, Sarah M Temkin, Sarah W Gordon, Sunil Gupta, Srinivasa R Jada
  Current Oncology. 2025-09-24
• Using Circulating Tumor DNA-Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine Cancer.
  Peter W Ketch, Carly Bess Scalise, Fernando Recio, Tara Berman, Nicole Hook
  JCO Precision Oncology. 2025-09-01

Journal Articles

• Two Classes of Cyclic AMP Binding Sites of Type II Protein Kinase Demonstrate Synergism When Added Together to Intact Adipocytes.  
  Beebe S; Holloway RW; Rannels SR; Corbin JD, J. Biol. Chem., 256:6
• Cefotan versus Cefoxitin as Prophylaxis in Hysterectomy.  
  Orr JW; Varner RE; Kilgore LC; McDiramid M; Holloway RW, Am. J. Obstet. Gynecol. 154:960-3
• Psammoma Bodies in Cervicovaginal Smear Associated with an Intrauterine Device.  
  Barter JF; Orr JW; Holloway RW; Hatch KD; Shingleton HM, J. Reprod. Med. 32:147-8
• Surgical Staging of Uterine Cancer. An analysis of perioperative morbidity.  
  Orr JW; Holloway RW; Orr PF; Holimon JL, Gynecol. Oncol. 42: 209-216
• Radiotherapy of Malignant Subdiaphragmatic Implants in Advanced Ovarian Carcinoma: A New Technique.  
  Pirkowski M; Holloway RW; Delgado G; Barnes W; Thomas D; Torrisi J; Popescu G; Rogers J; Dritchilo A, Int. J. Radiat. Oncol. Biol. Phys. 22: 1105-1108
• An Evaluation of Groshong Central Venous Catheters on a Gynecologic Oncology Service.  
  Holloway RW; Orr JW, Gynecol. Oncol. 56: 211-217
• Phase II Trial of Topotecan Combined with Cisplatin in Squamous and Non-Squamous Cervical Cancer, Preliminary Results.  
  Fiorica J; Grendys E; Holloway RW; Orr JW; Ndubisi B; DeCesare S; LaPolla J; Boothby R; Hoffman M; Arrango H, Gynecol. Oncol. 1441
• A Phase II Study to Determine the Efficacy and Tolerability of Intravenous ZD9331 in Heavily Pre-Treated Patients with Ovarian Cancer.  
  Rader JS; Clarke-Pearson D; Moore M; Carson L; Holloway RW; Kao MS; Wiznitzer I; Douglass EC, Gynecol. Oncol. 91:318-325
• Clinical-Pathologic and Morbidity Analyses of Types 2 and 3 Abdominal Radical Hysterectomy for Cervical Cancer.  
  Pikaart, DP; Holloway RW; Ahmad S; Finkler NJ; Bigsby IV GE; Ortiz BH; DeNardis SA, Gynecol. Oncol. 107: 205-210
• Metastatic Appendiceal Mucinous Adenocarcinoma to Well-Differentiated Diffuse Mesothelioma of the Peritoneal Cavity: A Mimicker of Florid Mesothelial Hyperplasia in As...  
  Tran T; Holloway RW; Finkler NJ, Int. J. Gynecol. Pathol. 27: 526-530
• Functional characterization of a fluorescent highly tumorigenic ovarian cancer cell line to test cellular therapy in experimental models.  
  Ingersoll SB, Ahmad S, Stoltzfus GP, Patel S, Radi MJ, Finkler NJ, Edwards JR, Holloway RW, Int. J. Gynecol. Cancer 2011; 21: 457-465
• Chemoradiation with adjuvant hysterectomy for stage IB-2 cervical cancer: 10 year experince.  
  Bigsby IV GE, Holloway RW, Ahmad S, Sombeck MD, Ebra G, Finkler NJ, Gynecol. Surg. 2011; [DPI: 10.1007/s10397-011-0717-1]
• Peri-operative outcomes of patients with stage IV endometriosis undergoing robotic-assisted laparoscopic surgery.  
  Brudie LA, Gaia G, Ahmad S, Finkler NJ, Bigsby IV GE, Ghurani GB, Kendrick IV JE, Rakowski JA, Groton JH, Holloway RW, J. Robotic Surg. 2011; 6
• Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells.  
  Turkson J, Oncogene 2012; 31: 2309-2322
• Short- and long-term complications and morbidity of robotic-assisted comprehensive endometrial cancer staging.  
  Backes FJ, Brudie LA, Farrell MR, Ahmad S, Finkler NJ, Bigsby GE, O’Malley D, Cohn DE, Holloway RW, Fowler JM, Gynecol. Oncol. 2012; 125: 546-551
• Operative outcomes and complications: Robotic versus abdominal hysterectomy for complex benign cases.  
  Beilan JA, Boardman LA, Johnson TR, Ahmad S, Bigsby GE, Finkler NJ, Holloway RW, Obstet. Gynecol
• Join now to see all

Books/Book Chapters

• Textbook of Gynecology. 
  Chapter: Intraoperative Techniques in Gynecologic Survey 
  Orr Jr JW and Holloway RWEditors: Copeland L.WB Saunders Company
• Textbook of Gynecology. 
  Chapter: Postoperative Care in Gynecologic Surgery 
  Orr Jr. JW and Holloway RWEditors: Copeland L.WB Saunders Company
• Gynecology and Obstetrics: A Longitudinal Approach. 
  Chapter: Perioperative Care 
  Page 741 - 752Orr Jr JW and Holloway RWEditors: Moore, Reiter, Rebar & Baker.Churchill Livingstone, Inc
• Gynecology and Obstetrics: A Longitudinal Approach. 
  Chapter: Neoplasia in Pregnancy 
  Page 385 - 395Orr Jr JW, Barrett JR, and Holloway RWEditors: Moore, Reiter, Rebar and Baker.Churchill Livingstone, Inc
• Proceedings of the 4th Annual Meeting of SERGS. 
  Chapter: Standardization of one approach to robotic-assisted pelvic and aortic lymphadenectomy for patients with endometrial cancer including the morbidly obese 
  Page 35 - 43Holloway RW, Ahmad SEditors: Lambaudie E, Narducci F.Marseille, France
• Robotic Gynecologic Surgery. 
  Chapter: Robotic pelvic and aortic lymphadenectomy for gynecologic malignancies – One approach 
  Kendrick JE IV, Ahmad S, Holloway RWEditors: Kilic SG, Ertan K, Kose F.European PublisherEdition 1,
• Join now to see all

Abstracts/Posters

• Analyses of gene expression and microRNA profiles in ovarian cancer cells and xenograph tumors: implications in aggressive tumor phenotype.
  Ciomek NA, Stoltzfus GP, Ahmad S, Merchant MH, Finkler NJ, Holloway RW, Ingersoll SB, 17th Annual Conference & Exhibition of the Society for Biomolecular Sciences, Orlando, FL
• Benchmarking robotic surgical performance: A 4-year analysis of annual peri-operative outcomes for patients with endometrial cancer treated with robotic-assisted lapar...
  Holloway RW, Ahmad S, Bigsby GE, Brudie LA, Rakowski, JA, Groton JH, Ghurani GB, Kendrick JE, Finkler NJ, J. Minim. Invasive Gynecol. 2011; 18 (Suppl.1): A528
• Peri-operative outcomes of patients with Stage IV endometriosis undergoing robotic-assisted laparoscopic surgery for relief of pain and adnexal masses.
  Brudie LA, Gaia G, Ahmad S, Finkler NJ, Bigsby GE, Ghurani GB, Kendrick JE, Rakowski JA, Holloway RW, J. Minim. Invasive Gynecol. 2011; 18 (Suppl.1): A329
• Robotic-assisted laparoscopic resection of sacral teratoma.
  Holloway RW, James JA, Rosen DS, Ahmad S, 3rd European Meeting on Robotic Gynecological Surgery of SERGS, Leuven, Belgium
• Annual peri-operative outcomes for patients with endometrial cancer treated robotically: A 4-year analysis.
  Holloway RW, Ahmad S, Bigsby IV GE, Brudie LA, Rakowski JA, Groton JH, Ghurani GB, Kendrick IV JE, Finkler NJ, 3rd European Meeting on Robotic Gynecological Surgery of SERGS, Leuven, Belgium
• Pilot study of robotic-assisted laparoscopic hysterectomy following chemoradiation for the treatment of stage IB-2 cervical carcinoma.
  Bigsby IV GE, Holloway RW, James JA, Brudie LA, Rakowski JA, Ahmad S, 3rd European Meeting on Robotic Gynecological Surgery of SERGS, Leuven, Belgium
• Inhibition of ovarian cancer cell growth by an NSAID, tolfenamic acid.
  Sankpal UT, Ingersoll SB, Ahmad S, Kaja S, Edwards JR, Holloway RW, Abdelrahim M, Basha R, International Gynecologic Cancer Society (IGCS) Regional Meeting on Gynecologic Cancers, New Delhi, India
• Analyses of survival outcomes for women with uterine malignancy undergoing robotic-assisted laparoscopic staging procedures.
  Brudie LA, Backes FJ, Ahmad S, Finkler NJ, Bigsby NJ, Cohn DE, O’Malley DM, Farrell M, Fowler JM, Holloway RW, International Gynecologic Cancer Society (IGCS) Regional Meeting on Gynecologic Cancers, New Delhi, India
• Usefulness of SKOV3-AF2 cell line in experimental cellular therapy treatments for ovarian cancer.
  Ingersoll SB, Ahmad S, Stoltzfus GP, Patel S, Radi MJ, Ciomek NA, Finkler NJ, Edwards JR, Holloway RW, International Gynecologic Cancer Society (IGCS) Regional Meeting on Gynecologic Cancers, New Delhi, India
• Evaluation of the cytotoxic response against ovarian cancer by immune effector cells isolated and expanded from healthy donors vs. patients or cord blood.
  Ingersoll SB, Stoltzfus GP, Merchant MH, Ahmad S, Ciomek NA, Edwards CR, Finkler NJ, Holloway RW, Cytotherapy 2011; 13 (Suppl.1): A217
• Robotic-assisted laparoscopic surgical staging of patients with clinical stage I adnexal cancers: Peri-operative outcomes.
  Holloway RW, Ahmad S, Finkler NJ, Bigsby GE, Ghurani GB, Kendrick JE, Brudie LA, Rakowski JA, James JA, J. Minim. Invasive Gynecol. 2011; 18 (Suppl.1): A136
• A novel therapeutic compound, tolfenamic acid, inhibits ovarian cancer cell growth: Therapeutic implications.
  Basha RM, Ingersoll SB, Sankpal UT, Ahmad S, Baker CH, Edwards JR, Holloway RW, Kaja S, Abdelrahim M, Proc. Am. Assoc. Cancer Res. 52: A2034
• Short- and long-term morbidity and outcomes after robotic surgery for endometrial cancer staging.
  Backes F, Brudie LA, Farrell M, Ahmad S, Finkler NJ, Bigsby GE, O’Malley D, Cohn D, Holloway RW, Fowler JM, Gynecol. Oncol. 2011; 120 (3; Suppl.1): A96
• Does uterine manipulator affect cervical cancer pathology or identification of lymphovascular space involvement?
  Rakowski JA, Radi MJ, Ahmad S, Brudie LA, James JA, Holloway, Gynecol. Oncol. 2011; 120 (3; Suppl.1): A60
• Survival outcomes for women with uterine malignancy undergoing robotic-assisted laparoscopic staging procedures.
  Brudie LA, Backes F, Ahmad S, Finkler NJ, Bigsby NJ, Cohn D, O’Malley D, Farrell M, Fowler JM, Holloway RW, Gynecol. Oncol. 2011; 120 (3; Suppl.1): A219
• Differential Cytotoxicity Response Elicited by UCB and PBMC Against Ovarian Cancer Cells.
  Ingersoll SB, Stoltzfus GP, Ahmad S, Edwards JR, Finkler NJ, Holloway RW, Cytotherapy 2010; 12 (Suppl.1), A32
• Tolfenamic acid inhibits ovarian cancer cells growth by targeting specificity protein transcription factors and decreasing the expression of c-met and surviving.
  Basha RM, Ingersoll SB, Ahmad S, Baker CH, Edwards JR, Holloway RW, Abdelrahim M, J. Clin. Oncol. 2010; 28 (15S, Part I of II), A-e15516
• Chemoradiation followed by adjuvant hysterectomy for the treatment of stage IB-2 cervix cancer: 10-year experience.
  Bigsby IV GE, Holloway RW, Ahmad S, Sombeck MD, Ebra G, Finkler NJ, J. Clin. Oncol. 2010; 28 (15S, Part I of II), A-5117
• Immunotherapy with intraperitoneal catumaxomab in patients with advanced ovarian cancer after a complete response to chemotherapy: A phase II study.
  Krasner C, Roche M, DeMars L, Williams J, Enke A, Klien A, Linke R, Holloway RW, J. Clin. Oncol. 2010; 28 (15S, Part I of II): A501
• Targeting Sp1 and survivin for potential ovarian cancer therapy: Comparative assessment of anti-cancer NSAID Tolfenamic acid and cisplatin.
  Sankpal UT, Ingersoll SB, Lee CM, McGann HC, Bhat VB, Khan M, Ahmad S, Holloway RW, Basha R, Proc. Am. Assoc. Cancer Res. 2012; Abstract # 4656
• Pegylated Liposomal Doxorubicin and Gemcitabine Therapy for Recurrent Ovarian Cancer; Updated Analysis of Outcomes and Long-term Survival.
  Holloway, RW, Finkler, NJ, Nye, L, Bigsby, G, Ortiz, BH, Poster Presentation SGO
• Clinico-pathological and surgical outcomes analyses of cervical cancer patients treated with robotic-assisted radical hysterectomy.
  Debruyne DVM, Holloway RW, Ahmad S, Bigsby GE, Ghurani GB, Kendrick JE, Finkler NJ, 14th Biennial Meeting of the International Gynecologic Cancer Society, Vancouver, Canada
• Ex vivo expansion of cytokine-induced killer cells from ovarian cancer patients is enhanced by IL-7 without promoting suppressor activity.
  Ingersoll SB, Ahmad S, McGann HC, Stavitzski NM, Stoltzfus GP, Finkler NJ, Edwards JR, Holloway RW, 14th Biennial Meeting of the International Gynecologic Cancer Society, Vancouver, Canada
• da Vinci robotic hysterectomy: Results of an international collaborative group pooled data analysis.
  Hebert T, Holloway RW, Gortchev G, Traen K, Goffin F, Ferrer C, Vergote I, Lambaudie E, Narducci F, Fastrez M, Voorhoof L, 4th Annual Meeting of SERGS, Marseille, France
• Robot assisted laparoscopic pelvic lymphadenectomy in gynecologic cancer patients.
  Goffin B, Sert B, Holloway R, Narducci F, Vergote I, Zanagnolo V, Ferrer C, Herbert T, Collinet P, Tran K, Timmermans M, Ahmad S, Leunen K, Hudry N, Boyon C, Segaert A..., Multicentric audit for the 2012 SERGS meeting, Marseille, France
• Join now to see all

Lectures

• Phase 1b study of oncolytic vaccinia virus GL-ONC1 in recurrent ovarian cancer (ROC). 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• Incorporating Robotics Into Your Practice: Tips on Para-Aortic Nodes. 
  San Francisco, CA
• Tips and Tricks for Robotic Para-aortic Lymphadenectomy. 
  Salt lake City, Utah
• Immunotherapy with intraperitoneal catumaxomab in patients with advanced ovarian-cancer after a complete response to chemotherapy: a phase II study. 
  Annual Meeting of the American Society of Clinical Oncology, Chicago, IL
• 2010 GOG/SGO/ASCO Update. 
  Hyatt Regency Grand Cypress, Orlando, FL
• State of the Art Robotic Surgery in Gynecologic Oncology. 
  Seoul, South Korea, 2010; Houston, Texas, 2011; Taipei, Taiwan, 2011
• Avoiding complications in Robotic Surgery. 
  World Robotic Symposium-Latin America, Sao Paolo, Brazil
• Tips for Success with Robotic Para-aortic Lymphadenectomy. 
  World Robotic Symposium-Latin America, Sao Paolo, Brazil
• Robotic Radical Hysterectomy Video Tutorial. 
  World Robotic Symposium-Latin America, Sao Paolo, Brazil
• Female Pelvic Anatomy for Gynecologic Surgeon. 
  Annual Meeting of the American Association of Gynecologic Laparoscopists (AAGL), Las Vegas, NV
• Focused Plenary Session V: Surgical Evolution and Cautionary Tale. 
  42nd Annual Meeting of the Society for Gynecologic Oncology (SGO), Orlando, FL
• Avoiding and Managing Complications with Robotic Surgery in Gynecology. 
  Washington, DC
• Infrarenal Pelvic and Aortic Lymphadenectomy Using da Vinci Robotic System: Pro-argument. 
  Miami Beach, FL
• Annual Peri-operative Outcomes for Patients with Endometrial Cancer Treated Robotically: A 4-Year Experience. 
  Leuven, Belgium
• Robotic Surgery in the Upper Abdomen in Ovarian Cancer. 
  Leuven, Belgium
• Infrarenal Pelvic and Aortic Lymphadenectomy Using da Vinci Robotic System. 
  World Robotic Symposium-Latin America, Sao Paolo, Brazil
• Robotic Surgery for Endometrial Cancer: A 4-Year Experience. 
  Pleven, Bulgaria
• Fluorescence Imaging via the Robot to Identify Sentinel Nodes. 
  Olympic Valley, CA
• Peri-aortic/Infra-renal Lymph Node Dissection: Two Surgeons. 
  Olympic Valley, CA
• Tips/Tricks and Deeply Invasive Endometriosis. 
  Miami Beach, FL
• Pelvic and Sentinel Lymph Node Detection and Nerve Sparing Concepts in Radical Hysterectomy. 
  Miami Beach, FL
• Robotic Surgery for Ovarian Cancer: at Montz/Innovative Robotic Symposium. 
  Austin, TX
• Detection of Sentinel Lymph Nodes in Patients with Endometrial Cancer Undergoing Robotic-Assisted Staging: A Comparison of Colorimetric and Fluorescence Imaging. 
  Austin, TX
• How to Manage Pelvic and Para-aortic Lymphadenectomy in Obese Patients (Isolated Para-aortic Lymphadenectomy). 
  Marseille, France
• Infra-renal para-aortic Dissection. 
  Marseille, France
• Join now to see all

Other

• The Carbon Dioxide Laser- A Guide to Its Use in Lower Genital Tract Disorders, Part I. 
  Holloway RW; Barnes WA; Barter JF
• The Carbon Dioxide Laser- A Guide to Its Use in Lower Genital Tract Disorders, Part II. 
  Holloway RW; Barnes WA; Barter JF, Female Patient 13(7):74-89